{
    "article_link": "https://doi.org/10.1038/s41586-021-04278-5",
    "data": [
        {
            "id": "data_1",
            "omics": "Genomics",
            "link": "https://ega-archive.org/",
            "format": "Processed Data",
            "source": "European Genome-Phenome Archive (EGA)",
            "public_id": "EGAS00001004582"
        },
        {
            "id": "data_2",
            "omics": "Transcriptomics",
            "link": "https://ega-archive.org/",
            "format": "Processed Data",
            "source": "European Genome-Phenome Archive (EGA)",
            "public_id": "EGAS00001004582"
        },
        {
            "id": "data_3",
            "omics": "Digital Pathology",
            "link": "",
            "format": "Digitized H&E Images",
            "source": "Cambridge University Hospitals NHS Foundation Trust",
            "public_id": ""
        },
        {
            "id": "data_4",
            "omics": "Clinical",
            "link": "",
            "format": "Clinical Metadata",
            "source": "Cambridge University Hospitals NHS Foundation Trust",
            "public_id": ""
        }
    ],
    "analyses": [
        {
            "id": "analysis_1",
            "analysis_name": "Differential analysis",
            "analysis_data": [
                "data_2"
            ],
            "label": {
                "RCB class": [
                    "pCR",
                    "residual disease"
                ]
            }
        },
        {
            "id": "analysis_2",
            "analysis_name": "Gene set enrichment analysis",
            "analysis_data": [
                "data_2",
                "MSigDB Hallmarks",
                "Reactome"
            ],
            "label": {
                "RCB class": [
                    "pCR",
                    "RCB-I",
                    "RCB-II",
                    "RCB-III"
                ]
            }
        },
        {
            "id": "analysis_3",
            "analysis_name": "Copy number calling",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "RCB class": [
                    "pCR",
                    "RCB-I",
                    "RCB-II",
                    "RCB-III"
                ]
            }
        },
        {
            "id": "analysis_4",
            "analysis_name": "Mutational signature decomposition",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "RCB class": [
                    "pCR",
                    "RCB-I",
                    "RCB-II",
                    "RCB-III"
                ]
            }
        },
        {
            "id": "analysis_5",
            "analysis_name": "HLA typing and neoantigen calling",
            "analysis_data": [
                "data_1",
                "data_2"
            ],
            "label": {
                "RCB class": [
                    "pCR",
                    "RCB-III"
                ]
            }
        },
        {
            "id": "analysis_6",
            "analysis_name": "iC10 classification",
            "analysis_data": [
                "data_1",
                "data_2"
            ],
            "label": {
                "RCB class": [
                    "pCR",
                    "RCB-I",
                    "RCB-II",
                    "RCB-III"
                ]
            }
        },
        {
            "id": "analysis_7",
            "analysis_name": "Ensemble machine learning model",
            "analysis_data": [
                "data_1",
                "data_2",
                "data_3",
                "data_4",
                "Treatment"
            ],
            "label": {
                "RCB class": [
                    "pCR",
                    "RCB-I",
                    "RCB-II",
                    "RCB-III"
                ],
                "Treatment_sequence": [
                    "taxane-first",
                    "anthracycline-first"
                ]
            }
        },
        {
            "id": "analysis_8",
            "analysis_name": "Clinical feature selection",
            "analysis_data": [
                "data_4"
            ],
            "label": {
                "RCB class": [
                    "pCR",
                    "residual disease"
                ]
            }
        },
        {
            "id": "analysis_9",
            "analysis_name": "Gene set variation analysis (GSVA)",
            "analysis_data": [
                "data_2"
            ],
            "label": {
                "RCB class": [
                    "pCR",
                    "RCB-I",
                    "RCB-II",
                    "RCB-III"
                ]
            }
        },
        {
            "id": "analysis_10",
            "analysis_name": "T cell dysfunction and exclusion analysis (TIDE)",
            "analysis_data": [
                "data_2"
            ],
            "label": {
                "HER2_status": [
                    "HER2−"
                ]
            }
        },
        {
            "id": "analysis_11",
            "analysis_name": "Monotonic association of predictor score with RCB class",
            "analysis_data": [
                "analysis_7"
            ],
            "label": {
                "RCB class": [
                    "pCR",
                    "RCB-I",
                    "RCB-II",
                    "RCB-III"
                ]
            }
        },
        {
            "id": "analysis_12",
            "analysis_name": "Clonal architecture analysis",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "RCB class": [
                    "pCR",
                    "residual disease"
                ]
            }
        },
        {
            "id": "analysis_13",
            "analysis_name": "Tumor mutation burden (TMB) analysis",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "RCB class": [
                    "pCR",
                    "RCB-I",
                    "RCB-II",
                    "RCB-III"
                ]
            }
        },
        {
            "id": "analysis_14",
            "analysis_name": "Mutational signature stratification by HER2 status",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "HER2_status": [
                    "HER2−"
                ]
            }
        },
        {
            "id": "analysis_15",
            "analysis_name": "PCA analysis of immune cell abundance",
            "analysis_data": [
                "data_2"
            ],
            "label": {
                "RCB class": [
                    "pCR",
                    "RCB-I",
                    "RCB-II",
                    "RCB-III"
                ]
            }
        },
        {
            "id": "analysis_16",
            "analysis_name": "Precision-recall analysis",
            "analysis_data": [
                "analysis_7"
            ],
            "label": {
                "RCB class": [
                    "pCR",
                    "RCB-I",
                    "RCB-II",
                    "RCB-III"
                ]
            }
        },
        {
            "id": "analysis_17",
            "analysis_name": "Hyperparameter optimization",
            "analysis_data": [
                "analysis_7"
            ],
            "label": {}
        },
        {
            "id": "analysis_18",
            "analysis_name": "Clinical + DNA Model",
            "analysis_data": [
                "data_1",
                "data_4"
            ],
            "label": {
                "RCB class": [
                    "pCR",
                    "RCB-I",
                    "RCB-II",
                    "RCB-III"
                ]
            }
        },
        {
            "id": "analysis_19",
            "analysis_name": "Clinical + RNA Model",
            "analysis_data": [
                "data_2",
                "data_4"
            ],
            "label": {
                "RCB class": [
                    "pCR",
                    "RCB-I",
                    "RCB-II",
                    "RCB-III"
                ]
            }
        },
        {
            "id": "analysis_20",
            "analysis_name": "Clinical + DNA + RNA Model",
            "analysis_data": [
                "data_1",
                "data_2",
                "data_4"
            ],
            "label": {
                "RCB class": [
                    "pCR",
                    "RCB-I",
                    "RCB-II",
                    "RCB-III"
                ]
            }
        },
        {
            "id": "analysis_21",
            "analysis_name": "Clinical + DNA + RNA + Digital Pathology Model",
            "analysis_data": [
                "data_1",
                "data_2",
                "data_3",
                "data_4",
                "Treatment"
            ],
            "label": {
                "RCB class": [
                    "pCR",
                    "RCB-I",
                    "RCB-II",
                    "RCB-III"
                ]
            }
        }
    ],
    "results": [
        {
            "analysis_id": "analysis_1",
            "metrics": "Odds ratio (OR), Confidence interval (CI), P-value",
            "value": "TP53: OR=2.9, CI=1.3–6.6, P=0.01; PIK3CA: OR=2.1, CI=1.3–3.4, P=0.002",
            "features": [
                "TP53 mutations",
                "PIK3CA mutations",
                "EGFR overexpression",
                "MYC overexpression",
                "CCNE1 overexpression",
                "CDKN2A overexpression"
            ]
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "Normalized enrichment score",
            "value": "Proliferation: P=0.0005; Immune activation: P=0.001",
            "features": [
                "Proliferation",
                "Immune activation"
            ]
        },
        {
            "analysis_id": "analysis_3",
            "metrics": "P-value",
            "value": "P=0.0002",
            "features": [
                "Copy number alterations",
                "Chromosomal instability"
            ]
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "Odds ratio (OR), P-value",
            "value": "HRD: OR=1.1, P=0.006; APOBEC: OR=1.1, P=0.02",
            "features": [
                "HRD score",
                "APOBEC signature"
            ]
        },
        {
            "analysis_id": "analysis_5",
            "metrics": "Odds ratio (OR), Confidence interval (CI), P-value",
            "value": "HLA class I locus LOH: OR=3.5, CI=1.1–14.2, P<0.05; Neoantigen load: pCR median=28, residual disease median=17",
            "features": [
                "HLA class I locus LOH",
                "Neoantigen load"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "Pearson residuals",
            "value": "iC10: overrepresented in pCR; iC3, iC7, iC8: underrepresented in pCR",
            "features": [
                "iC10 subtypes",
                "iC3 subtypes",
                "iC7 subtypes",
                "iC8 subtypes"
            ]
        },
        {
            "analysis_id": "analysis_7",
            "metrics": "AUC, DeLong confidence interval",
            "value": "AUC=0.87 (training), AUC=0.87 (validation); DeLong CI=0.87±0.03",
            "features": [
                "Age",
                "Lymphocyte density",
                "PGR expression",
                "ESR1 expression",
                "ERBB2 expression",
                "Tumor mutation burden (TMB)",
                "HRD score",
                "GGI score",
                "STAT1 score",
                "Chemotherapy cycles",
                "HER2-targeted therapy",
                "Chromosomal instability",
                "Treatment_sequence"
            ]
        },
        {
            "analysis_id": "analysis_7",
            "metrics": "z-score",
            "value": "RNA features: highest contribution; Lymphocyte density: z-score=1.2",
            "features": [
                "RNA features",
                "Lymphocyte density"
            ]
        },
        {
            "analysis_id": "analysis_7",
            "metrics": "Number of non-responders identified",
            "value": "31 non-responders identified with 0 false negatives",
            "features": []
        },
        {
            "analysis_id": "analysis_8",
            "metrics": "AUC",
            "value": "AUC=0.70",
            "features": [
                "Tumor grade",
                "ER status",
                "HER2 status",
                "Lymph node involvement"
            ]
        },
        {
            "analysis_id": "analysis_9",
            "metrics": "Normalized enrichment score",
            "value": "GGI score: P=2×10⁻⁵; Embryonic stem-cell metagene: P=0.0001; STAT1 immune signature: P=0.00001",
            "features": [
                "GGI score",
                "Embryonic stem-cell metagene",
                "STAT1 immune signature"
            ]
        },
        {
            "analysis_id": "analysis_10",
            "metrics": "P-value",
            "value": "T cell dysfunction: P=0.006 (HER2−); T cell exclusion: P=0.02",
            "features": [
                "T cell dysfunction score",
                "T cell exclusion score"
            ]
        },
        {
            "analysis_id": "analysis_11",
            "metrics": "P-value",
            "value": "P=3×10⁻⁶ (training), P=1×10⁻⁶ (validation)",
            "features": [
                "Predictor score"
            ]
        },
        {
            "analysis_id": "analysis_12",
            "metrics": "P-value",
            "value": "Subclonal mutations higher in residual disease (P=0.04, pCR vs RCB-II)",
            "features": [
                "Clonal mutations",
                "Subclonal mutations",
                "Clonal diversity"
            ]
        },
        {
            "analysis_id": "analysis_13",
            "metrics": "Median TMB, P-value",
            "value": "TMB pCR: 2.3, residual disease: 1.4, P=0.0005",
            "features": [
                "Tumor mutation burden (TMB)"
            ]
        },
        {
            "analysis_id": "analysis_14",
            "metrics": "Stratified odds ratio (OR), P-value by HER2 status",
            "value": "HRD: OR=1.1, P=0.006; APOBEC: OR=1.1, P=0.02",
            "features": [
                "HRD score",
                "APOBEC signature"
            ]
        },
        {
            "analysis_id": "analysis_15",
            "metrics": "PCA score",
            "value": "Distinct clustering of immune cell types in pCR vs. residual disease",
            "features": [
                "Cytotoxic T cells",
                "Regulatory T cells",
                "Mast cells",
                "Cancer-associated fibroblasts"
            ]
        },
        {
            "analysis_id": "analysis_16",
            "metrics": "Average precision, Area under precision-recall curve, Precision, Recall",
            "value": "Average precision=0.68; Area under precision-recall curve=0.67; Precision=0.65; Recall=0.70",
            "features": [
                "RNA features",
                "Lymphocyte density",
                "Clinical metadata"
            ]
        },
        {
            "analysis_id": "analysis_17",
            "metrics": "Optimized hyperparameters",
            "value": "Fivefold cross-validation used to optimize hyperparameters",
            "features": [
                "Logistic regression",
                "Support vector machine",
                "Random forest"
            ]
        },
        {
            "analysis_id": "analysis_18",
            "metrics": "AUC",
            "value": "AUC=0.80",
            "features": [
                "Clinical metadata",
                "Genomic features"
            ]
        },
        {
            "analysis_id": "analysis_19",
            "metrics": "AUC",
            "value": "AUC=0.86",
            "features": [
                "Clinical metadata",
                "Transcriptomic features"
            ]
        },
        {
            "analysis_id": "analysis_20",
            "metrics": "AUC",
            "value": "AUC=0.86",
            "features": [
                "Clinical metadata",
                "Genomic features",
                "Transcriptomic features"
            ]
        },
        {
            "analysis_id": "analysis_21",
            "metrics": "AUC",
            "value": "AUC=0.85",
            "features": [
                "Clinical metadata",
                "Genomic features",
                "Transcriptomic features",
                "Digital pathology"
            ]
        }
    ]
}